EUVIMEDEUVIMED entdecken
Crossref

Integration of Pharmacodynamics, Proteomics, and Metabolomics to Elucidate Effect and Mechanism of Rehmanniae Radix in the Treatment of T2DM

Jingru Liang, Chenyang Zhu, Jimin Park, Qiuxia Yu, Yu Zhong, Nan Guo, Zhonglian Cao, Zhenhan Zhu, Shiwei Yan, Tiandian Wang, Jiarong Hu, Haiyang Liu und 4 weitere

The FASEB Journal · 2025

DOI: 10.1096/fj.202501294r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Jingru Liang und 15 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, State Key Laboratory of Advanced Drug Formulations for Overcoming Delivery Barriers, Fudan University, Shanghai, C…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Rehmannia, Diabetes Mellitus, Experimental, Hypoglycemic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rehmanniae Radix (RR) has a long history in treating type 2 diabetes mellitus (T2DM). It was previously shown to alleviate T2DM through the regulation of molecular targets in the kidney. However, the role of RR on T2DM‐driven hepatic metabolism disorder remains unclear. This study aimed to elucidate the therapeutic effects of RR against T2DM and reveal its mechanism of action in the liver. In this study, a high‐fat diet and streptozotocin‐induced T2DM rat model were used to investigate the antidiabetic effect of Rehmanniae Radix extract (RRE). Proteomics and metabolomics of rat serum and livers were employed to predict antidiabetic targets and metabolic pathways of RRE in the treatment of T2DM. After 5‐week oral administration, low, medium, and high doses of RRE all exhibited significant hypoglycemic effects, notably improving insulin resistance in T2DM rats. Additionally, 78 differentially expressed proteins returning to normal levels were identified in the serum, whereas 83 and 69 differentially expressed metabolites returning to normal levels were identified in the serum and liver, respectively. KEGG enrichment analysis from the proteomics and metabolomics data revealed enrichment of both ATP‐binding cassette (ABC) transporters and multiple lipid metabolism‐related pathways, which are highly associated with the antidiabetic effect of RRE. Pearson's correlation analysis showed significant correlations between differential proteins involved in cholesterol metabolism and differential metabolites related to lipid metabolism pathways in serum and liver. Furthermore, RT‐qPCR results demonstrated significant downregulation of mRNA levels of ATP‐binding cassette transporter A1 (Abca1) and ATP‐binding cassette subfamily G member 5 (Abcg5), upregulation of mRNA level of Glucose transporter type 1 (Glut1) and a decrease in hepatic glycogen content in the RRE‐treated T2DM rats. In conclusion, RRE exhibits a potent antidiabetic effect by downregulating Abca1 and Abcg5 to inhibit hepatic cholesterol efflux, promoting low‐density lipoprotein cholesterol clearance, upregulating Glut1 to increase hepatic glucose uptake, and lowering blood glucose levels, thereby improving glucose and lipid metabolism disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2RehmanniaDiabetes Mellitus, ExperimentalHypoglycemic AgentsPlant ExtractsDrugs, Chinese HerbalAnimalsRatsProteomicsMaleMetabolomicsRats, Sprague-DawleyLiverLipid MetabolismDiet, High-FatInsulin Resistance

Stichwörter der Autor:innen

Rehmanniae Radixmetabolomicsproteomicstraditional Chinese medicinetype 2 diabetes mellitus

Substanzen

Hypoglycemic AgentsPlant ExtractsDrugs, Chinese Herbalrehmannia root

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, State Key Laboratory of Advanced Drug Formulations for Overcoming Delivery Barriers, Fudan University, Shanghai, China.
  • Department of Biochemistry and Molecular Biology, School of Medicine, Indiana University, Indianapolis, Indiana, USA.
  • Department of Pharmacy, Minhang Hospital, Fudan University, Shanghai, China.
  • Department of Microbiology and Immunology, School of Medicine, Indiana University, Indianapolis, Indiana, USA.

ORCID-Profile: Guo Ma

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)
  • National Natural Science Foundation of China

Zitieren

APA

Liang, J., Zhu, C., Park, J., Yu, Q., Zhong, Y., Guo, N., Cao, Z., Zhu, Z., Yan, S., Wang, T., Hu, J., Liu, H., Chow, J., Li, L., Hu, X., & Ma, G. (2025). Integration of Pharmacodynamics, Proteomics, and Metabolomics to Elucidate Effect and Mechanism of Rehmanniae Radix in the Treatment of T2DM. The FASEB Journal. https://doi.org/10.1096/fj.202501294r

Vancouver

Liang J, Zhu C, Park J, Yu Q, Zhong Y, Guo N, et al. Integration of Pharmacodynamics, Proteomics, and Metabolomics to Elucidate Effect and Mechanism of Rehmanniae Radix in the Treatment of T2DM. The FASEB Journal. 2025. doi:10.1096/fj.202501294r

BibTeX
@article{Liang2025,
  author = {Liang, Jingru and Zhu, Chenyang and Park, Jimin and Yu, Qiuxia and Zhong, Yu and Guo, Nan and Cao, Zhonglian and Zhu, Zhenhan and Yan, Shiwei and Wang, Tiandian and Hu, Jiarong and Liu, Haiyang and Chow, Junwei and Li, Longzhou and Hu, Xinyi and Ma, Guo},
  title = {Integration of Pharmacodynamics, Proteomics, and Metabolomics to Elucidate Effect and Mechanism of Rehmanniae Radix in the Treatment of T2DM},
  journal = {The FASEB Journal},
  year = {2025},
  doi = {10.1096/fj.202501294r}
}
Kostenlos starten →